Actos
Actos (Pioglitazone) is used to control high blood sugar in type 2 diabetes (non-insulin-dependent diabetes mellitus).
| Product dosage: 15mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.00 (0%) | 🛒 Add to cart |
| 90 | $0.83 | $85.50 $75.00 (12%) | 🛒 Add to cart |
| 120 | $0.78 | $114.00 $93.00 (18%) | 🛒 Add to cart |
| 180 | $0.72 | $171.00 $129.00 (25%) | 🛒 Add to cart |
| 240 | $0.69 | $228.00 $166.00 (27%) | 🛒 Add to cart |
| 360 | $0.66
Best per pill | $342.00 $239.00 (30%) | 🛒 Add to cart |
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.00 (0%) | 🛒 Add to cart |
| 90 | $0.77 | $78.00 $69.00 (12%) | 🛒 Add to cart |
| 120 | $0.72 | $104.00 $86.00 (17%) | 🛒 Add to cart |
| 180 | $0.66 | $156.00 $118.00 (24%) | 🛒 Add to cart |
| 270 | $0.63 | $234.00 $169.00 (28%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $312.00 $217.00 (30%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Advair Diskus: Dual-Action Control for Asthma and COPD
Advair Diskus is a prescription-only combination inhaler designed for the long-term maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. It combines two distinct medications—a corticosteroid (fluticasone propionate) to reduce inflammation and a long-acting bronchodilator (salmeterol) to relax airway muscles—in a single, easy-to-use device. This dual-mechanism approach provides comprehensive airway management, helping to prevent symptoms such as wheezing, shortness of breath, and chest tightness. It is not intended for immediate relief of acute bronchospasm.
Seroflo: Advanced Dual-Action Asthma and COPD Control
Seroflo represents a significant advancement in the management of obstructive airway diseases, combining two established therapeutic agents into a single, convenient inhaler. This fixed-dose combination therapy integrates an inhaled corticosteroid (ICS) and a long-acting beta2-agonist (LABA) to address both the underlying inflammation and bronchoconstriction characteristic of asthma and chronic obstructive pulmonary disease (COPD). Its development is grounded in the GINA (Global Initiative for Asthma) and GOLD (Global Initiative for Chronic Obstructive Lung Disease) strategy documents, which recommend such combinations for patients requiring Step 3 or 4 therapy or those with frequent exacerbations.
Tiova Inhaler: Precision Bronchodilation for COPD Control
Tiova Inhaler (Tiotropium Bromide) is a long-acting muscarinic antagonist (LAMA) inhaler designed for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It provides sustained bronchodilation by targeting airway smooth muscle, offering patients a cornerstone therapy for daily symptom management and improved lung function. Its once-daily dosing regimen supports adherence, while its specific mechanism of action helps reduce the frequency of exacerbations and improve exercise tolerance.
Tiova Rotacap: Advanced Bronchodilation for COPD Management
Tiova Rotacap is a high-efficacy, long-acting muscarinic antagonist (LAMA) designed for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Its unique dry powder formulation, delivered via the Rotahaler device, ensures consistent and deep lung deposition, offering sustained bronchodilation and improved respiratory function. This medication is engineered to reduce exacerbation frequency, enhance exercise tolerance, and support daily symptom control in patients with moderate to severe airflow limitation.
Xyzal: Advanced 24-Hour Relief from Allergic Rhinitis and Chronic Hives
Xyzal (levocetirizine dihydrochloride) is a modern, prescription-strength antihistamine designed to provide sustained, 24-hour relief from the most challenging allergy symptoms and chronic idiopathic urticaria. As the active enantiomer of cetirizine, it delivers targeted histamine H1-receptor blockade with enhanced efficacy and a favorable pharmacokinetic profile. This medication represents a significant advancement in allergy management, offering patients robust symptom control with once-daily dosing convenience. Its well-established safety profile makes it suitable for long-term management of allergic conditions in appropriate patient populations.
Astelin Nasal Spray: Fast-Acting Relief for Allergic Rhinitis Symptoms
Astelin (azelastine hydrochloride) is a prescription antihistamine nasal spray clinically proven to provide rapid relief from seasonal and perennial allergic rhinitis symptoms. As a second-generation antihistamine with additional anti-inflammatory properties, Astelin targets multiple pathways in the allergic response, offering comprehensive symptom management. Its topical administration delivers medication directly to the nasal passages, minimizing systemic exposure while maximizing therapeutic effect. Trusted by allergists and ENT specialists, Astelin represents a sophisticated approach to allergy management with demonstrated efficacy in clinical trials.
Asthalin: Fast-Acting Relief for Acute Bronchospasm
Asthalin (salbutamol sulfate) is a rapid-onset, short-acting beta-2 adrenergic agonist (SABA) bronchodilator indicated for the treatment and prevention of bronchospasm in reversible obstructive airway diseases, including asthma and chronic obstructive pulmonary disease (COPD). As a first-line rescue medication, it works by selectively relaxing smooth muscle in the airways, facilitating improved airflow within minutes of administration. Available in multiple formulations—metered-dose inhaler (MDI), dry powder inhaler (DPI), nebulizer solution, and tablets—Asthalin offers flexibility in acute and maintenance therapy, making it a cornerstone in respiratory management protocols worldwide.
Claritin: Non-Drowsy 24-Hour Allergy Relief with Loratadine
Claritin (loratadine) is a second-generation, non-sedating antihistamine indicated for the effective management of seasonal and perennial allergic conditions. As a selective peripheral H1-receptor antagonist, it works by blocking the action of histamine, a key chemical mediator responsible for allergic symptoms, without significantly crossing the blood-brain barrier. This mechanism provides potent symptom control while minimizing central nervous system effects, making it a first-line recommendation for patients requiring uninterrupted daytime alertness. Available in multiple formulations, including tablets, orally disintegrating tablets, and syrup, Claritin offers flexible and convenient dosing for adults and pediatric populations aged 2 years and above.
Combimist L Inhaler: Dual-Action Relief for Asthma and COPD
Combimist L Inhaler is a pressurized metered-dose inhaler (pMDI) containing a fixed-dose combination of Levosalbutamol and Ipratropium Bromide. It is indicated for the treatment and management of reversible airways obstruction, such as in asthma and chronic obstructive pulmonary disease (COPD). This combination therapy offers both rapid bronchodilation and sustained control, making it a cornerstone in respiratory management for patients requiring dual bronchodilator therapy. Its optimized formulation ensures efficient drug delivery to the lower airways, providing comprehensive symptom relief and improved lung function.